<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03922659</url>
  </required_header>
  <id_info>
    <org_study_id>2019-12-TMSCBT-H</org_study_id>
    <nct_id>NCT03922659</nct_id>
  </id_info>
  <brief_title>Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence</brief_title>
  <acronym>THED</acronym>
  <official_title>Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heroin dependence is one of most common substance dependence, which brings great burden on
      health worldwide. Heroin dependence may lead to immunosuppression and cognitive impairments.
      Once heroin dependence is developed, it will be difficult to recover and easy to relapse.
      Although many efforts had been made in the treatment of heroin dependence, the annual
      recurrence of heroin dependence with traditional therapies would be up to 90%. Repetitive
      transcranial magnetic stimulation (rTMS) on the dorsolateral prefrontal cortex (DLPFC) or
      cognitive behavioral therapy (CBT) each alone was reported to have some effect on preventing
      from relapse of substance dependence. In order to test whether combined therapy of high
      frequency rTMS (hf-rTMS) with CBT is better for preventing from relapse of heroin dependence,
      we recruit patients with heroin dependence to participate this study. The study is a
      factorial designed and the patients will be assigned into one of the following six groups
      randomly: (1) regular treatment (symptomatic treatment) with blank TMS; (2) regular treatment
      (RT) with blank TMS and CBT; (3) RT with right DLPFC hf-rTMS; (4) RT with right DLPFC hf-rTMS
      and CBT; (5) RT with left DLPFC hf-rTMS; (6) RT with left DLPFC hf-rTMS and CBT. TMS was
      given 5 days per week for total 2 weeks using uniform scheme (5 seconds of 10Hz stimulation
      per train, 30 trains per day with inter-train interval of 20 seconds). CBT will be given once
      per week for total 8 weeks. The patients will be followed up for 6 months. Recurrence of
      heroin dependence, duration of abstention, heroin/drug intake, craving for heroin and other
      cognitive psychological assessments will be recorded and compared among the 6 treatment
      groups and the efficacy of combined therapy of rTMS with CBT will be evaluated in our study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of heroin dependence</measure>
    <time_frame>1 month</time_frame>
    <description>The rate of relapse of heroin dependence after discharge from hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of heroin dependence</measure>
    <time_frame>2 month</time_frame>
    <description>The rate of relapse of heroin dependence after discharge from hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of heroin dependence</measure>
    <time_frame>3 month</time_frame>
    <description>The rate of relapse of heroin dependence after discharge from hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrence of heroin dependence</measure>
    <time_frame>6 month</time_frame>
    <description>The rate of relapse of heroin dependence after discharge from hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of abstinence</measure>
    <time_frame>6 months</time_frame>
    <description>The total time or period without any intake of heroin during follow-ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heroin consumption</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Diaries of heroin intake in different time of the follow-ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Craving for heroin</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Craving assessment for heroin by Heroin Craving Questionnaire (HCQ) ranging from 0 to 175. Higher score of HCQ indicates more desire for heroin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Craving for heroin</measure>
    <time_frame>2weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Craving assessment by Visual Analogue Scale (VAS) for heroin desire ranging 0 to 10. Higher score indicates more desire for heroin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive assessment</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Cognitive assessment by Montreal Cognitive Assessment (MoCA) ranging from 0 to 30. Lower score indicates worse cognitive function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Anxiety</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Generalized Anxiety Disorder-7 (GAD-7) ranging from 0 to 21. Higher score indicates more severer anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Depression</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Patient Health Questionnaire-9 (PHQ-9) ranging from 0 to 27. Higher score indicates more severer depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Sleep</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Pittsburgh Sleep Quality Index (PSQI) ranging from 0 to 21. Higher score indicates worse sleep.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Heroin Dependence</condition>
  <arm_group>
    <arm_group_label>Regular treatment (symptomatic treatment) with blank TMS</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Regular treatment (symptomatic treatment) with blank transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular treatment (RT) with blank TMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment (symptomatic treatment) with blank transcranial magnetic stimulation and cognitive behavioral therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with right DLPFC hf-rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with right dorsolateral prefrontal cortex (DLPFC) high frequency repetitive transcranial magnetic stimulation (hf-rTMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with right DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with right DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS) and cognitive behavioral therapy (CBT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with left DLPFC hf-rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with left DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with left DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with left DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS) and cognitive behavioral therapy (CBT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Transcranial magnetic stimulation and Cognitive behavioral therapy</intervention_name>
    <description>Transcranial magnetic stimulation on different side with/without cognitive behavioral therapy</description>
    <arm_group_label>RT with left DLPFC hf-rTMS</arm_group_label>
    <arm_group_label>RT with left DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_label>RT with right DLPFC hf-rTMS</arm_group_label>
    <arm_group_label>RT with right DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_label>Regular treatment (RT) with blank TMS and CBT</arm_group_label>
    <arm_group_label>Regular treatment (symptomatic treatment) with blank TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis as heroin dependence according to DSM-IV criteria

          -  No definite history of neurological diseases and psychological problems

          -  Volunteer to participate the study, cooperate to be followed up

        Exclusion Criteria:

          -  Acute withdrawal state and CIWA score &gt; 9

          -  With other neurological diseases and psychological problems

          -  With ever brain trauma and damage

          -  With other psychological medications or other substance dependence

          -  With other contraindications to have transcranial magnetic stimulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ying Peng, MD, PhD</last_name>
    <phone>+86-13380051581</phone>
    <email>pengy2@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hongxuan Wang, MD, PhD</last_name>
    <phone>+86-13824498978</phone>
    <email>wanghx8@mail.sysu.edu.cn</email>
  </overall_contact_backup>
  <reference>
    <citation>Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009 Jun 13;373(9680):2041-53. doi: 10.1016/S0140-6736(09)60660-7.</citation>
    <PMID>19524780</PMID>
  </reference>
  <reference>
    <citation>Makani R, Pradhan B, Shah U, Parikh T. Role of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment of Addiction and Related Disorders: A Systematic Review. Curr Drug Abuse Rev. 2017;10(1):31-43. doi: 10.2174/1874473710666171129225914. Review.</citation>
    <PMID>29189190</PMID>
  </reference>
  <reference>
    <citation>Shen Y, Cao X, Tan T, Shan C, Wang Y, Pan J, He H, Yuan TF. 10-Hz Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex Reduces Heroin Cue Craving in Long-Term Addicts. Biol Psychiatry. 2016 Aug 1;80(3):e13-4. doi: 10.1016/j.biopsych.2016.02.006. Epub 2016 Feb 12.</citation>
    <PMID>26995024</PMID>
  </reference>
  <reference>
    <citation>Herremans SC, Vanderhasselt MA, De Raedt R, Baeken C. Reduced intra-individual reaction time variability during a Go-NoGo task in detoxified alcohol-dependent patients after one right-sided dorsolateral prefrontal HF-rTMS session. Alcohol Alcohol. 2013 Sep-Oct;48(5):552-7. doi: 10.1093/alcalc/agt054. Epub 2013 May 24.</citation>
    <PMID>23709633</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2019</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Ying Peng</investigator_full_name>
    <investigator_title>Professor, Director of Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>Heroin dependence, transcranial magnetic stimulation, cognitive behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heroin Dependence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

